Eric Jonasch

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Topics

Cerebrospinal Fluid

Cross Sectional

Dna Damage Response

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Orphanet journal of rare diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Tobias Else, Eric Jonasch, Othon Lliopoulos, Kathryn E Beckermann, Vivek Narayan, Benjamin L Maughan, Stephane Marie Oudard, Jodi K Maranchie, Ane B Iversen, Cynthia Muller Goldberg, Wei Fu, Rodolfo F Perini, Yanfang Liu, W Marston Linehan, Ramaprasad Srinivasan
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Tobias Else, Eric Jonasch, Othon Lliopoulos, Kathryn E Beckermann, Vivek Narayan, Benjamin L Maughan, Stephane Marie Oudard, Jodi K Maranchie, Ane B Iversen, Cynthia Muller Goldberg, Wei Fu, Rodolfo F Perini, Yanfang Liu, W Marston Linehan, Ramaprasad Srinivasan
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Eric Jonasch, Yan Song, Jonathan Freimark, Richard Berman, Ha Nguyen, James Signorovitch, Murali Sundaram
Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States. Orphanet journal of rare diseases 19 (1) (2024)
Tobias Else, Eric Jonasch, Othon Lliopoulos, Kathryn E Beckermann, Vivek Narayan, Benjamin L Maughan, Stephane Marie Oudard, Jodi K Maranchie, Ane B Iversen, Cynthia Muller Goldberg, Wei Fu, Rodolfo F Perini, Yanfang Liu, W Marston Linehan, Ramaprasad Srinivasan
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Tobias Else, Eric Jonasch, Othon Lliopoulos, Kathryn E Beckermann, Vivek Narayan, Benjamin L Maughan, Stephane Marie Oudard, Jodi K Maranchie, Ane B Iversen, Cynthia Muller Goldberg, Wei Fu, Rodolfo F Perini, Yanfang Liu, W Marston Linehan, Ramaprasad Srinivasan
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Eric Jonasch, Yan Song, Jonathan Freimark, Richard Berman, Ha Nguyen, James Signorovitch, Murali Sundaram
Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States. Orphanet journal of rare diseases 19 (1) (2024)
Tobias Else, Eric Jonasch, Othon Lliopoulos, Kathryn E Beckermann, Vivek Narayan, Benjamin L Maughan, Stephane Marie Oudard, Jodi K Maranchie, Ane B Iversen, Cynthia Muller Goldberg, Wei Fu, Rodolfo F Perini, Yanfang Liu, W Marston Linehan, Ramaprasad Srinivasan
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Eric Jonasch, Yan Song, Jonathan Freimark, Richard Berman, Ha Nguyen, James Signorovitch, Murali Sundaram
Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States. Orphanet journal of rare diseases 19 (1) (2024)
Luigi Perelli, Federica Carbone, Li Zhang, Justin K Huang, Courtney N Le, Hania Khan, Francesca Citron, Edoardo Del Poggetto, Tony Gutschner, Hideo Tomihara, Melinda Soeung, Rosalba Minelli, Sanjana Srinivasan, Michael Peoples, Truong Nguyen Anh Lam, Sebastian Lundgren, Ruohan Xia, Cihui Zhu, Alaa M T Mohamed, Jianhua Zhang, Kanishka Sircar, Alessandro Sgambato, Jianjun Gao, Eric Jonasch, Giulio F Draetta, P Andrew Futreal, Ziad Bakouny, Eliezer Van Allen, Toni K Choueiri, Sabina Signoretti, Pavlos Msaouel, Kevin Litchfield, Samra Turajlic, Linghua Wang, Ying-Bei Chen, Renzo G DiNatale, A Ari Hakimi, Virginia Giuliani, Timothy P Heffernan, Andrea Viale, Christopher A Bristow, Nizar M Tannir, Alessandro Carugo, Giannicola Genovese
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer. Nature cancer (2023)
Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail, Xuesong Zhang, Truong Nguyen Anh Lam, Anh Hoang, Elshad Hasanov, Ganiraju C Manyam, Christine B Peterson, Haifeng Zhu, Shwetha V Kumar, Rehan Akbani, Patrick G Pilié, Nizar M Tannir, Guang Peng, Eric Jonasch
SETD2 loss and ATR inhibition synergize to promote cGAS signaling and immunotherapy response in renal cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Francesco Gatto, Sinisa Bratulic, Eric Jonasch, Angelo Limeta, Francesca Maccari, Fabio Galeotti, Nicola Volpi, Sven Lundstam, Jens B Nielsen, Ulrika Stierner
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study. JCO precision oncology 7 (2023)
Francesco Gatto, Sinisa Bratulic, Eric Jonasch, Angelo Limeta, Francesca Maccari, Fabio Galeotti, Nicola Volpi, Sven Lundstam, Jens B Nielsen, Ulrika Stierner
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study. JCO precision oncology 7 (2023)
Andrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, Tharakeswara K Bathala, Andrew J Wiele, Matthew T Campbell, Amado J Zurita, Amishi Y Shah, Eric Jonasch, Jianjun Gao, Sangeeta Goswami, Omar Alhalabi, Priya Rao, Kanishka Sircar, Nizar M Tannir, Pavlos Msaouel
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy. The oncologist (2023)
Francesco Gatto, Sinisa Bratulic, Eric Jonasch, Angelo Limeta, Francesca Maccari, Fabio Galeotti, Nicola Volpi, Sven Lundstam, Jens B Nielsen, Ulrika Stierner
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study. JCO precision oncology 7 (2023)
Vivek Narayan, Eric Jonasch
Systemic Therapy Development in Von Hippel-Lindau Disease: An Outsized Contribution from an Orphan Disease. Cancers 14 (21) (2022)
Eric Jonasch, Michael B Atkins, Simon Chowdhury, Paul Mainwaring
Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts? Cancers 14 (3) (2022)
Pavlos Msaouel, Sangeeta Goswami, Peter F Thall, Xuemei Wang, Ying Yuan, Eric Jonasch, Jianjun Gao, Matthew T Campbell, Amishi Yogesh Shah, Paul Gettys Corn, Alda L Tam, Kamran Ahrar, Priya Rao, Kanishka Sircar, Lorenzo Cohen, Sreyashi Basu, Fei Duan, Sonali Jindal, Yuwei Zhang, Hong Chen, Shalini Singh Yadav, Ronald Shazer, Hirak Der-Torossian, James P Allison, Padmanee Sharma, Nizar M Tannir
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Science translational medicine 14 (641) (2022)
Matthew T Campbell, Surena F Matin, Alda L Tam, Rahul A Sheth, Kamran Ahrar, Rebecca S Slack Tidwell, Priya Rao, Jose Antonio Karam, Christopher G Wood, Nizar M Tannir, Eric Jonasch, Jianjun Gao, Amado J Zurita, Amishi Yogesh Shah, Sonali Jindal, Fei Duan, Sreyashi Basu, Hong Chen, Alexsandra B Espejo, James P Allison, Shalini S Yadav, Padmanee Sharma
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nature communications 12 (1) (2021)
Andrew J Wiele, Tharakeswara K Bathala, Andrew W Hahn, Lianchun Xiao, Munevver Duran, Jeremy A Ross, Eric Jonasch, Amishi Yogesh Shah, Matthew T Campbell, Pavlos Msaouel, Nizar M Tannir
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies. The oncologist 26 (6) (2021)
Toni K Choueiri, Todd M Bauer, Kyriakos P Papadopoulos, Elizabeth R Plimack, Jaime R Merchan, David F McDermott, M Dror Michaelson, Leonard J Appleman, Sanjay Thamake, Rodolfo F Perini, Naseem J Zojwalla, Eric Jonasch
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis. Nature medicine 27 (5) (2021)
Daniel J McGrail, Patrick G Pilié, Hui Dai, Truong Nguyen Anh Lam, Yulong Liang, Leonie Voorwerk, Marleen Kok, Xiang H F Zhang, Jeffrey M Rosen, Amy B Heimberger, Christine B Peterson, Eric Jonasch, Shiaw-Yih Lin
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers. Science translational medicine 13 (617) (2021)
Eric Jonasch, Cheryl Lyn Walker, W Kimryn Rathmell
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nature reviews. Nephrology 17 (4) (2020)
Jing Zhang, Tao Wu, Jeremy M Simon, Mamoru Takada, Ryoichi Saito, Cheng Fan, Xian-De Liu, Eric Jonasch, Ling Xie, Xian Chen, Xiaosai Yao, Bin Tean Teh, Patrick Tan, Xingnan Zheng, Mingjie Li, Cortney Lawrence, Jie Fan, Geng-Xi Jiang, Xijuan Liu, Lianxin Hu, Jun Wang, Chengheng Liao, Kai Hong, Giada Zurlo, Joel S Parker, James T Auman, Charles M Perou, W Kimryn Rathmell, William Y Kim, Marc W Kirschner, William G Kaelin, Albert S Baldwin, Yang Zhang
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science (New York, N.Y.) 361 (6399) (2018)